← Back to Search

Online Cancer Screening & HPV Vaccination Strategy for Cervical Cancer Prevention

N/A

Waitlist Available

Led By Lara Savas, PhD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8-month follow up

Awards & highlights

Study Summary

This trial will develop and test an online strategy to help increase breast and cervical cancer screening and HPV vaccination rates for Latinas.

Who is the study for?

This trial is for Latinas aged 21-65 who haven't had a Pap test in the last 3 years, those aged 50-75 without a mammogram in the past 2 years, and those aged 21-26 who haven't started HPV vaccination. Participants must intend to use SEMM and be served by clinics with LHWs that cater to Latina populations in Texas.Check my eligibility

What is being tested?

The study is testing 'Salud en Mis Manos' (SEMM), an internet platform designed to improve breast/cervical cancer screening and HPV vaccination among Latinas. It compares usual implementation practices against SEMM with extra support strategies.See study design

What are the potential side effects?

Since this trial focuses on implementing a screening and vaccination program rather than testing new medications, it does not have typical medication side effects. However, there may be discomfort or other minor effects from the screening procedures or vaccinations.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8-month follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8-month follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Effectiveness (for HPV vaccination) as measured by the percentage of female patients who initiate or complete an HPV vaccination among all eligible patients.

Effectiveness (for screening) as measured by the percentage of women who complete cervical cancer screening (Pap or HPV screening test) among all eligible patients.

Effectiveness (for screening) as measured by the percentage of women who complete mammogram screening among all eligible patients.

+8 more

Secondary outcome measures

Cost effectiveness of SEMM-DIA in community and clinic practice settings

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Salud en Mis Manos - Dissemination and Implementation AssistanceExperimental Treatment1 Intervention

The multi-component and multi-faceted implementation strategy SEMM-DIA

Group II: Salud en Mis Manos - Usual Implementation PracticeActive Control1 Intervention

The SEMM-Usual Implementation Practice arm includes all existing SEMM program materials.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

903 Previous Clinical Trials

318,977 Total Patients Enrolled

1 Trials studying Cancer Prevention

1,554 Patients Enrolled for Cancer Prevention

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,475,402 Total Patients Enrolled

Lara Savas, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

3 Previous Clinical Trials

16,770 Total Patients Enrolled

Media Library

Salud en Mis Manos - Dissemination and Implementation Assistance Clinical Trial Eligibility Overview. Trial Name: NCT05524480 — N/A

Cancer Prevention Research Study Groups: Salud en Mis Manos - Dissemination and Implementation Assistance, Salud en Mis Manos - Usual Implementation Practice

Cancer Prevention Clinical Trial 2023: Salud en Mis Manos - Dissemination and Implementation Assistance Highlights & Side Effects. Trial Name: NCT05524480 — N/A

Salud en Mis Manos - Dissemination and Implementation Assistance 2023 Treatment Timeline for Medical Study. Trial Name: NCT05524480 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any possibility of me participating in this clinical trial?

"This study requires 2000 participants between ages 21 and 75, who have not been screened for cancer in the past few years. In addition to this requirement, applicants should also be affiliated with a clinic/community health centre that provides low-cost or no cost screening services to Latinas from lower-income backgrounds; they must express an interest in SEMM implementation; and meet criteria such as having unmet breast or cervical cancer prevention needs (according to USPSTF guidelines). Women aged 21 - 26 must have never initiated HPV vaccination either. Note: individuals may fit into more than one 'non-adherent' group if they are missing multiple"

Answered by AI

Are there any vacancies for participants in this trial?

"According to the clinicaltrials.gov resource, this particular trial is not currently seeking patients. It was initially posted on November 16th 2022 and last updated on August 29th 2022. Despite being closed for enrollment, there are 320 other studies actively searching for participants at this time."

Answered by AI

Does this research encompass those over forty years of age?

"According to the research criteria, individuals joining this clinical trial should be between 21 and 75 years old. Simultaneously, 11 studies are recruiting participants below 18 while 286 trials are searching for volunteers over 65."

Answered by AI